TheAccomplishmentsandLegacyofSaulHertz,MD
BennettS.Greenspan1,MichaelS.Hofman2,3,andJohnBuscombe4
1DepartmentofRadiology,AugustaVAMedicalCenter,Augusta,Georgia; 2ProstateCancerTheranosticsandImagingCentreof Excellence,DepartmentofMolecularImagingandTherapeuticNuclearMedicineCancerImaging,PeterMacCallumCancerCentre, Melbourne,Victoria,Australia; 3SirPeterMacCallumDepartmentofOncology,UniversityofMelbourne,Melbourne,Victoria, Australia;and 4DepartmentofNuclearMedicine,CambridgeUniversityHospitals,Cambridge,UnitedKingdom
Theearlyhistoryoftheuseofradioactiveiodine(RAI)iscomplicated andinteresting,andalsodifficulttodiscover,especiallysinceseveral historieshavepresentedinaccuratecontent.ThisarticleisacomprehensivereviewoftheaccomplishmentsofSaulHertz.Extensiveuse ofprimary-sourceverificationhasclarifiedseveralissues,including thequestionofwhetherHertzaloneconceivedandaskedthepivotal question: “Couldiodinebemaderadioactiveartificially?”;onwhat dateRAIwas firstusedtotreathyperthyroidism;andwhy2articleson the firstuseofRAIfortreatmentofhyperthyroidism,from2different setsofauthorsfromthesamedepartmentofthesameinstitution, appearedadjacenttoeachotherinthesameissueofthe Journalof theAmericanMedicalAssociation in1946.Ourreviewalsochronicles severalmajorchallengesthatHertzovercametoproducehispivotal work.HertzwasclearlytheoriginatorandavisionaryofRAItherapyin benignandmalignantthyroiddisease.Webelievehecanbeconsideredoneofthefathersofnuclearmedicine.Hertz’sparadigmchangingworkwasapivotalmedicaldiscoveryofthe20thcentury. ThelegacyofHertzcontinueswhiletheapplicationofRAItherapy continuestoevolve.RAItherapyremainsthepreferredtreatmentin mostsituationsforautonomousnodulesandtoxicmultinodulargoiter andremainsasafeandeffectivetreatmentforGravesdiseaseafter morethan80yofglobalclinicaluse.RAItreatmentofdifferentiated thyroidcancerremainsa first-linetreatmentformostpatientsafter surgery,especiallyforthosewithintermediate-orhigh-riskdisease.
KeyWords: SaulHertz;radioactiveiodine;hyperthyroidism;thyroid cancer;theranostics
JNuclMed2024;65:659–663 DOI:10.2967/jnumed.124.267524
Inthelandscapeofmedicalhistoryandinnovation,few figures exemplifytheblendofgroundbreakingscientificachievementand selflessserviceaswellasSaulHertzdoes.BornonApril20, 1905,Hertz’sjourneyinmedicinebeganwithhisgraduationfrom HarvardMedicalSchoolin1929,atimeofstrictquotasforoutsiders.HeservedaschiefoftheThyroidUnitatMassachusettsGeneralHospital(MGH)from1931to1943.Despitethepromiseofa burgeoningresearchandclinicalcareer,Hertz’spathtookadetour asheansweredthecallofduty,servingasacommanderinthe U.S.NavyduringthetumultuousyearsofWorldWarIIfrom 1943to1945.Tragically,hislifeandcareerwerecutshortwhen
ReceivedJan.26,2024;revisionacceptedJan.30,2024. Forcorrespondenceorreprints,contactBennettS.Greenspan(bengreenspan 0708@gmail.com).
PublishedonlineMar.7,2024.
COPYRIGHT 2024bytheSocietyofNuclearMedicineandMolecularImaging.
hepassedawayonJuly28,1950,attheageof45becauseofa myocardialinfarction,asconfirmedbyautopsy.ThisreviewarticleseekstoexplorenotjusttheprofessionalmilestonesofHertz butalsothepersonalandhistoricalcontextthatshapedhisremarkable,albeittoobrief,journeythroughlifeandmedicine(Table1).
Fourscientificadvancementsanddiscoveriesprovidethebasis forthepivotalquestionandsubsequentresearchandclinicalwork ofHertz.Theseincludetheunderstandingoftheroleofiodinein thyroidmetabolismandfunction,thediscoveryofradioactivity, thedevelopmentofthetracerprinciple,andtheproductionofartificialradioactivity(1).
OnNovember12,1936,KarlCompton,presidentoftheMassachusettsInstituteofTechnology,presentedtothefacultyatthe HarvardMedicalSchoolaguestlectureentitled, “WhatPhysics CanDoforBiologyandMedicine” aspartofaweeklylecture seriesandluncheon.Attheconclusionofthelecture,Hertzsolely conceivedandspontaneouslyaskedthepivotalquestion “Could iodinebemaderadioactiveartificially?” KarlComptonwasuncertainandsaidhewouldlookintoit.HewrotebacktoHertzon December15,1936,apologizedforthedelayedresponse,and wrote, “Iodinecanbemadeartificiallyradioactive.” Infact,Enrico Fermihadproduced 128Iin1934,andearlierin1934,Frederic JoliotandIreneJoliot-Curiecreatedartificialradioactivity,for whichtheyreceivedtheNobelPrizeforChemistryin1935.LettersbetweenHertzandComptonmakeitclearthattheideaof usingradioactiveisotopestostudymetabolismcamesolelyfrom Hertz(1–4).ThefactthatHertzsolelyaskedthequestionwasconfirmedbyJamesMeans,chiefofmedicalservicesatMGH,ina lettertotheMarkleFoundation(Fig.3in(2))inwhichhestated, “whenitbecameapparentthattheremightberadioactiveisotopes ofiodine,itatonceoccurredtoHertzthatwemightmakeuseof themtosolveaproblemwewerealreadyworkingon” (1–5).RobleyEvans,directoroftheMassachusettsInstituteofTechnology RadiationLaboratory,alsowrotealetterofrecommendationto theNavyconfirmingthatHertzwastheonewhoconceivedthe ideaofusingradioactiveiodine(RAI)forresearchandtherapyof thyroiddisease(5).
HertzcollaboratedwithArthurRoberts,amedicalphysicist whowashiredatMassachusettsInstituteofTechnologybyRobleyEvans.EarleChapmanwasanendocrinologistintheMGH ThyroidClinic.WhenHertzwasleavingMGHtojointheNavyin 1943,HertzaskedChapmantosupervisetheclinicaltrialsandfollowtheestablishedprotocols,towhichChapmanagreed.However,Chapmanchangedtheprotocols.JohnStanburywasan endocrinologistintheThyroidClinic,whowroteabookonthe historyoftheMGHThyroidClinicfrom1913to1990.Unfortunately,thebookcontainedsignificantmisinformation.Roberts wrotealettertoStanburyonApril3,1991,inanattempttocorrect
TABLE1
AccomplishmentsofSaulHertz
Accomplishment
fi c
Scienti
Year
1932Firsttocombinethyroidmetabolismwithdiscoveryofradioactivity( fi rstpublicationonbloodpictureinexophthalmicgoiter)( 10 )
1936Conceivedandaskedseminalquestion: “ Couldiodinebemaderadioactivearti fi cially? ”
1937FirsttopublishpreclinicalstudyofRAImetabolisminrabbits*
FirsttopublishtraceruseofRAIinstudyingthyroidphysiology( 1 –3 )
1937FirsttoconceiveofusingRAIforbiomedicalinvestigation,andoneof fi rsttouseradiotracersastoolsforbiomedicalresearch( 1 –3 )
FirsttodemonstratelinkagebetweenRAIuptakeandthyroidfunction,includingeffectsofthyroid-stimulatinghormoneanddiet
Firsttoconceiveofusinguptakemeasurementfordiagnosisandforadministeredactivitycalculation
Firsttousemolecularlytargetedtherapy
FirsttouseRAIinpatients
FirsttouseRAIasboththerapeuticagentanddiagnosticagent(theranostics)
Firsttoconceiveofpharmacologicinterventionforresearchandclinicalstudies,extendingclinicalutilityofdiagnostictestsandenhancingth erapy
FirsttouseRAIasbiomarker
1937FirsttosuggestthatRAImayalsobeusedtotreatthyroidcancer( 1 , 2 ) †
1941FirsttousetherapeuticRAIinclinicatMGH( 1 , 8 )
FirsttodemonstratesafetyandsuccessofRAItherapyforhyperthyroidism
1942FirsttouseRAItotreatpatientwiththyroidcancer
FirsttopresentRAItreatmentofhyperthyroidism(alongwithArthurRoberts,presentedtoMarkleFoundationresultsoftreatmentof fi rst10hyperthyroid patients)
JournaloftheAmericanMedicalAssociation ( 8 )
1946Publishedresultsof fi rst29patientsin
Administrative
1943ServedasdirectorofMGHThyroidUnit
1931 –
1937 –1946Oneofthe fi rstphysicianstocollaboratewithamedicalphysicist(ArthurRoberts)
1946FounderofRadioactiveIsotopeResearchInstitute
StrongproponentofmakingRAIwidelyavailablebyurgingAtomicEnergyCommissiontodoso
HelpedpromotepeacefulusesofatomicenergybydevelopingeffectiveusesofRAI,advocatingwidedistributionandavailabilityofRAIwithreasona blecost, andissuingguidelinesforsafety
Developedcurriculum(togetherwithArthurRoberts)inappliednuclearphysicsforphysiciansandbiologists
1949Established fi rstnuclearmedicinedepartment(atMassachusettsWomen ’ sHospital)
*Hertzdemonstratedremarkabledisciplineinproceedingsystematicallyfromexplorationofconceptinpreclinicalanimalstudies,includingstu diesoffunctionandsafety,tosuccessful clinicaluseofRAIinpatientsfordiagnosisandtreatment.Hertz ’ suseofdosimetry,RAIuptaketesting,andRAIastracerandbiomarkerareenduringessentialsofprecisiontargeted approach.
† HertzsuggestedthatRAItherapyofthyroidcancerwasamodelforradiopharmaceuticaltherapiesforcancerandthattherapyofothertypesofcancerm ightbeaddressedinthe future. “ MynewresearchisinCanceroftheThyroidwhichIbelieveholdsthekeytothelargerproblemofCanceringeneral. ” LetterbyHertztoMGH( 4 ).
TABLE2

versionmadeusing hotpot.ai deeplearning.)
themisinformation.Robertsalsostatedintheletter, “Evansmade itaconditionofmyemploymentthathisnamewastoappearon allpublications” (2).HertzandRobertsincludedEvansonthe first 2papers,butnotafterthat,sinceEvansneverparticipatedinany ofthestudies(5).ItistobenotedthatHertzandRobertsdesigned theresearch,executedthework,analyzedthedata,andwrotethe papers(4).Evanswasnotinvolvedinanyofthoseactivities. Evansdirectedthelaboratorythatinitiallyprovidedtheneutron sourcetoproduceRAI.TheMassachusettsInstituteofTechnology cyclotronproducedgreaterquantitiesofRAIthatwerecritically importantforRAItherapy.
Althoughitisoftenassumedscienceandscientificendeavor occurinaworldisolatedfromtheprejudicesandmoresofthe time,thisissadlyhardlyeverthecase.AtthetimeHertzwas workingandpublishinghisresearch,hewaslivingandworkingin acityinwhichantisemiticopinionandactionshadbecomecommonplace.Inthe1930s,Bostonwasthemostanti-Jewishcityin theUnitedStatesandtheheadquartersofanorganizationcalled theChristianFront(6).Until1941,thisorganization,atthevery
AwardsandHonorsReceivedbySaulHertz
YearAwardorhonor
1931–1933DaltonScholar,MGH
1935–1937HenryPickeringWolcottFellow,Harvard MedicalSchool
1940KeytoScience/SigmaXiChapterof MassachusettsInstituteofTechnology
1941ElectedmemberofAmericanSocietyfor ClinicalInvestigation(“YoungTurks” Society)
1946HonorableMention,AmericanGoiter AssociationVanMeterAward
2021*HonoredbyAmericanChemicalSociety withNationalHistoricalChemical landmarkdesignationatMGH
HonoredbyU.S.Congressforpioneering workindevelopingmedicalapplications forRAI
2023*Asoriginatorofprecisiontargeted personalizedmedicine,honoredby NortheasternChapterofAmerican ChemicalSocietywithSaulHertz MemorialSymposium
*Posthumouslyhonored.
timethatHertzwasworkinginBoston,was financedandledby thenationalsocialist(Nazi)governmentinGermany.Evenafter theUnitedStatesenteredthewaragainstGermany,theorganizationcontinuedto flourishandorganizeantisemiticprotestmarches throughthestreetsofBoston.Theorganizationwasimplicatedin physicalattacksonJewishmenandboysuptotheendof1943.
Hertzfacedandovercameseveralmajorchallengesduringhis career:pushbackfromsurgeons,whowereconcernedthathewas takingbusinessfromthem;interruptionofhisclinicalstudiesby WorldWarII;questionableethicsinmedicalpublishing(ghost authoring);otherstryingtostealcreditforhiswork;andconfrontationwithstrictquotasandrestrictions hewasatargetofpersonalandsystemicantisemitism.

ThetruestoryofHertzincludeselementsofexploitation,failure tohonorthosewhoservedinthewar, greed,stolenintellectualproperty,and antisemitism.Evansdeliberatelymuddied thewatersastothetruthregarding whetherHertzwastheonewhoaskedthe pivotalquestion.Thetruthwasexplained inApril2016byMGH’schairmanemeritusoftheDepartmentofRadiology, JamesThrall,whostated, “… Chapman andEvanshadbasicallystolenHertz’s work themost flagrant,unethical,academicallyreprehensiblebehavior … worst yet .ChapmanandEvansspenta greatdealoftimeandeffortrewritinghistory” (7).
FIGURE2. BostonTraveler newspaperofSeptember30,1949,announcingnewresearchdivision whereradioactiveisotopesweretobeusedinstudyandtreatmentofdisease.
In1946,therewere2adjacentpublicationsinthesameMay11issueof Journal
CategoryLegacy
Revolutionizingof ThyroiddiseasemanagementwithuseofRAItherapy,whichhasbecomestandardofcarefor benignthyroiddisease(hyperthyroidism)andfordifferentiatedthyroidcancer(papillaryand follicularcell)
Establishmentof
Developmentof
Cultureofcollaboration(betweenphysiciansandphysicists,betweendepartments,between institutions,andwithgovernmentagencies)
Cultureofsafety(patientsafetyandproposalofreviewprocesstoinvestigateinfringementof rightsofphysiciansbyhospitalboards)
Theranosticapproachforcancertherapy
Nuclearmedicineasmedicalspecialty
Detectiondevice(multiscaleruptakeprobe,whichisbelievedtohaveinfluenceddevelopment ofrectilinearscanner[BennedictCassen,1950]and g-camera[HalAnger,1958])
Radiotracerfordetectabilityandlocalization,andsubsequentuseofmanydifferent radiotracersindiagnosisandtreatment
Realizationof Useofdosimetryforeffectivetreatmentusingpersonalizedtargetedtherapy
Increasinguseof
Continuingevolutionof
Eponymof …
Radiopharmaceuticaltherapyformanydifferentcancers*
ApplicationsofRAItherapy,whichremainspreferredinmostsituationsforautonomous nodulesandtoxicmultinodulargoiter,remainssafeandeffectiveforGravesdiseaseafter morethan80yofclinicaluseworldwide,andremains first-linetreatmentformost differentiatedthyroidcancerpatientsaftersurgery,especiallythosewithintermediateor high-riskdisease(useofdosimetryisincreasinglyrecognizedasvaluableintreatmentof thyroiddisease;tumorheterogeneityhasbeenidentifiedaskeyfactorlimitingresponseto targetedtreatmentssuchas 131I;andimagingwith 124Iand 18F-FDGPET/CThasrolein selectingpatientsanddirectingtherapy,markingnewareaofpersonalizedmedicine)
SaulHertzWorldTheranosticsDay(celebratingongoinginnovationandadvancementin field ofnucleartheranostics)†
SaulHertzAwardandSymposium,SocietyofNuclearMedicineandMoleculeImaging(lifetime achievementawardforoutstandingcontributionstoradionuclidetherapy)
SaulHertzYoungInvestigatorAward,SouthAfricanSocietyofNuclearMedicine
SaulHertzYoungInvestigatorAward,IndianSocietyofNuclearMedicine
SaulHertzYoungInvestigatorAward,PakistanSocietyofNuclearMedicine
SaulHertzMemorialPrize,BritishNuclearMedicineSociety(bestoralpaperandbestpaper concerningscienceordeliveryofradionuclidetherapy)
SaulHertzMemorialLecturePreceptorship,ProstateTheranosticsandImagingCentreof Excellence
*Hertzwasquotedin TheAmericanWeeklyMagazine onJune2,1946,assaying “… demandisexpectedinthe fieldsofcancerand leukaemiaforotherradioactivemedicines.”
†OnMarch31,1941,usingMassachusettsInstituteofTechnologycyclotron-producedRAI,Hertzinitiallyusedmixtureof 130I(90%) and 131I(10%)totreatGravesdiseasepatientElizabethD.ThisdateisnowestablishedasSaulHertzWorldTheranosticsDay.He presentedresultsof first10patientsin1942toMarkleFoundation.Initially,29patientsweretreated,andresultswerepublishedin5-y follow-upin JournaloftheAmericanMedicalAssociation in1946.Twentyof29wereconsideredcured,and6othershadpartialresponse toRAItherapy(1–3).
oftheAmericanMedicalAssociation, fromthesamelaboratoryon thesametopic the firstsuccessfuluseofRAItotreathyperthyroidism.Theeditorofthatjournalfrom1924to1950wasMorris Fishbein,whowasawareoftheprevious6papersbyHertzand Roberts.He firstreceivedapaperfromChapmanandEvans.Fishbeinsentitbackforrevision,sinceitwastoolong.Fishbeinwas alsoconcernedthatthestudiesonthesametopicfromthesame laboratorydidnotincludeHertzandRobertsanddidnotevenreferencethem.FishbeincontactedMeans,whoassuredFishbeinthat theChapmanandEvansarticlewaslegitimateandthattheirarticle wasbasedonaseriesofdifferentpatients.Fishbeincontacted Hertzandaskedhimtosubmithispaperwiththeresultsofhis first clinicaltrial,whichhedid.Afternegotiation,Fishbeinpublished
bothpapersnexttoeachotherandplacedtheHertzandRoberts paper first,toacknowledgetheirpioneerstatus,sincethosestudies weredone first(8,9).Thisissueisdiscussedfurtherinapaperby ObaldoandHertz(5).
HistoryrecordsHertz,withRoberts,asapioneerofRAItherapyandasestablishingnuclearmedicineasanewspecialtyof medicine(Figs.1and2).Hertzcreatedadynamicandenduring fundamentalchangeinmodernmedicine.Heinfluencedtheconvergenceofthesciencesandcollaborativeteamsaswellastheuse ofuptaketestinganddosimetrytodevelopprecisiontargetedmedicine.Hislegacylivesontoday(Tables2and3).
WealsoacknowledgeJohnLawrenceforuseof 32Pfortreatmentofleukemiain1936andpolycythemiaverain1937.Atthe
LawrenceBerkeleyNationallaboratory,Lawrence’steamwas alsoinvestigatingRAIinthelate1930sandearly1940sandbegan treatinghyperthyroidpatientsinOctober1941(1).AlsoacknowledgedisCharlesPecherfortreatmentofbonesarcomawith 89Sr in1941.Today,westandontheshouldersofthesegiantsaswe continueoureffortstodevelopnext-generationtheranostics.
DISCLOSURE
Nopotentialconflictofinterestrelevanttothisarticlewasreported.
ACKNOWLEDGMENT
WeacknowledgeBarbaraHertz,whoprovidedthe2 figuresand primarysourcematerialforthisarticle.
REFERENCES
1.FaheyFH,GrantFD.Celebratingeightyyearsofradionuclidetherapyandthe workofSaulHertz. JApplClinMedPhys. 2021;22:4–10.
2.HertzB.Dr.SaulHertz(1905–1950)discoversthemedicalusesofradioactive iodine:the firsttargetedcancertherapy.In:AhmadzadehfarH,ed.Thyroid Cancer:AdvancesinDiagnosisandTherapy.IntechOpen;2016:1 – 14.
3.FaheyFH,GrantFD,ThrallJH.SaulHertz,MD,andthebirthofradionuclide therapy. EJNMMIPhys. 2017;4:15–23.
4.HertzB.AtributetoDr.SaulHertz:thediscoveryofthemedicalusesofradioiodine. WorldJNuclMed. 2019;18:8–12.
5.ObaldoJM,HertzBE.Theearlyyearsofnuclearmedicine:aretelling. AsiaOcean JNuclMedBiol. 2021;9:207–219.
6.GallagherCR. NazisofCopleySquare:TheForgottenStoryoftheChristianFront. HarvardUniversityPress;2021:1–336.
7.ThrallJH. MGHRussellMuseumpresentation,SaulHertz:radioiodineandthe originsofnuclearmedicine https://www.youtube.com/watch?v=34Qhm8CeMuc PublishedApril13,2016.AccessedFebruary20,2024.
8.HertzS,RobertsA.Radioactiveiodineinthestudyofthyroidphysiology;the useofradioactiveiodinetherapyinhyperthyroidismVII. JAmMedAssoc. 1946;131:81–86.
9.ChapmanEM,EvansED.Thetreatmentofhyperthyroidismwithradioactive iodine. JAmMedAssoc. 1946;131:86–91.
10.HertzS,LermanJ.Thebloodpictureinexophthalmicgoitreanditschangesresultingfromiodineandoperation.Astudybymeansofthesupravitaltechnique. JClinInvest. 1932;11:1179–1196.